Effects of Dronabinol (Oral THC) on Cannabis Use
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials
| City: |
|
Baltimore |
| State: |
|
Maryland |
| Zip Code: |
|
21224 |
| Conditions: |
|
Marijuana Smoking |
| Purpose: |
|
The number of people seeking treatment for marijuana-related problems is on the rise, yet
there is no currently accepted medication proven to help them quit. This research is
designed to determine whether the FDA approved medication dronabinol (Marinol®) has effects
that might help make it easier for people to stop daily marijuana use, and to carefully
study the occurence of safety risks and side-effects at different doses of the drug.
|
| Study Summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Current use of marijuana
- Able to give informed consent
Exclusion Criteria:
- Daily use of psychoactive medication
- Current Axis I psychiatric disorder other than dependence on cannabis or nicotine, or
abuse of drugs or alcohol
- Women who are pregnant, breast feeding, or planning to become pregnant within the
next 3 months
- Those seeking treatment for cannabis-related problems or using cannabis under the
guidance of a physician for a medical disorder
- Uncontrolled or unstable cardiovascular disease
- Allergy to sesame oil
|
| NCT ID: |
|
NCT01394185 |
| Primary Contact: |
|
Principal Investigator
Ryan Vandrey, Ph.D.
Johns Hopkins University
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Baltimore, Maryland 21224
United States
There is no listed contact information for this specific location.
Site Status: N/A |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
June 19, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|